跳至主要内容
临床试验/CTRI/2016/02/006652
CTRI/2016/02/006652尚未招募未知

Randomized trial comparing the efficacy of Dapsone and Azathioprine as second-line therapy in patients with steroid refractory or steroid dependent immune thrombocytopenia (ITP).

Institution sponsored0 个研究点目标入组 500 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion Criteria: Patients diagnosed to have ITP (confirmed on bone marrow examination), who meet the following criteria:
  • Steroid refractory ITP - Defined as platelet count <30,000/mm3 after standard steroid therapy (Prednisolone 1mg/kg for 1 month) or High dose Dexamethasone (40mg OD for 4 days)
  • Steroid dependent ITP: Defined as initial response to steroid therapy (Partial or
  • complete) with recurrence of severe thrombocytopenia ( <30,000/mm3) upon taper of steroids.

排除标准

  • 1)Secondary ITP â?? Other known autoimmune disorder (Rheumatoid arthritis, SLE, Hypothyroidism), Drugs, HIV, Pregnancy
  • 2)Known G6PD deficiency
  • 3)ITP with life-threatening bleeds â?? IC bleeds, GI bleeds.

研究者

发起方
Institution sponsored

相似试验